By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ReVance Therapeutics, Inc. 

2400 Bayshore Parkway, Suite 100

Mountain View  California  94043  U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
ReVance Therapeutics, Inc. (RVNC) Provides Update On RT001 Clinical Program For The Lead Indication For Crow's Feet Lines 10/2/2014 7:50:29 AM
ReVance Therapeutics, Inc. (RVNC) Announces The Appointment Of Azita Nejad As Vice President Of Quality 9/23/2014 7:38:53 AM
ReVance Therapeutics, Inc. (RVNC) Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/3/2014 7:20:37 AM
ReVance Therapeutics, Inc. (RVNC) Appoints Industry Veteran Arthur P. Bertolino, M.D., Ph.D., M.B.A. As Chief Medical Officer 8/12/2014 3:23:34 PM
ReVance Therapeutics, Inc. (RVNC) Releases Second Quarter 2014 Financial Results 8/12/2014 3:19:15 PM
ReVance Therapeutics, Inc. (RVNC) To Release Second Quarter 2014 Financial Results And Host Conference Call On Tuesday, August 12, 2014 7/30/2014 8:05:26 AM
ReVance Therapeutics, Inc. (RVNC) Announces Closing Of Its Follow-On Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 6/25/2014 8:44:40 AM
ReVance Therapeutics, Inc. (RVNC) Announces Pricing Of Its Public Offering Of Common Stock 6/19/2014 8:53:07 AM
ReVance Therapeutics, Inc. (RVNC) Announces Proposed Public Offering Of Common Stock 6/17/2014 9:15:44 AM
ReVance Therapeutics, Inc. (RVNC) Announces Participation In Jefferies and Co. 2014 Global Healthcare Conference 5/22/2014 9:09:57 AM
1234
//-->